Investigation of adverse effects and healing factor properties of a novel formulation from Blue-O Medical Technology – Phase II

The appearance of multidrug resistance of pathogens poses challenges for researchers and industrial communities to develop more efficacious antimicrobial treatments1. Blue-O Technology Incorporation (Blue-O Tech) has developed a novel formulation of medicine that accelerates the wound healing process, while having an excellent antimicrobial strength over a broad spectrum of pathogens. Skin is the first physical barrier of the body that prevents the internalization of microorganisms. At the same time, it is a reservoir of approximately 1000 different bacterial species distributed across 19 phyla.

(MISSING)

Faculty Supervisor:

Horacio Bach

Student:

Partner:

Blue-O Technology Inc.

Discipline:

Life Sciences

Sector:

Health and Related Sciences & Technology

University:

The University of British Columbia